J Mateo

Summary

Affiliation: Hospital de la Santa Creu i Sant Pau
Country: Spain

Publications

  1. ncbi request reprint Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)
    J Mateo
    Haematology Department, Hospital de Sant Pau, Barcelona, Spain
    Blood Coagul Fibrinolysis 9:71-8. 1998
  2. ncbi request reprint Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs
    Jose Mateo
    Thrombosis and Hemostasis Unit, Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Thromb Haemost 95:386-7. 2006
  3. ncbi request reprint Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis
    J M Soria
    Unitat d Hemostàsia i Trombosi Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Blood 95:2780-5. 2000
  4. ncbi request reprint Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies
    I Tirado
    Thrombosis and Hemostasis Unit, Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Haematologica 86:1200-8. 2001
  5. ncbi request reprint Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Avda Sant Antoni Ma Claret 167, 08025 Barcelona, Spain
    Haematologica 84:627-32. 1999
  6. ncbi request reprint The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barceolan, Spain
    Thromb Haemost 80:366-9. 1998
  7. ncbi request reprint Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients
    A Santamaria
    Thrombosis and Hemostasis Unit, Department of Hematology, Universitat Autonoma de Barcelona, Hospital de Santa Creu i Sant Pau, Barcelona, Spain
    Int J Clin Pract 61:1819-23. 2007
  8. ncbi request reprint Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels
    A Santamaria
    Department of Hematology, Hospital de la Santa Creu i Sant Pau, C Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain
    Stroke 34:2387-91. 2003
  9. doi request reprint [Limitations of anticoagulant therapy]
    J Marti-Fabregas
    Unidad de Enfermedades Vasculares Cerebrales, Servicio de Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Neurologia 27:27-32. 2012
  10. ncbi request reprint Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Thromb Haemost 85:88-92. 2001

Collaborators

  • J C Souto
  • J Marti-Fabregas
  • Amparo Santamaria Ortiz
  • S Biondo
  • M Navarro
  • Montserrat Borrell
  • Jordi Fontcuberta
  • A Santamaria
  • I Tirado
  • A Oliver
  • C Santos
  • A Vidal-Jordana
  • J M Soria
  • M Constans
  • R Belvis
  • Amparo Santamaria
  • X Sanjuan
  • R Frago
  • E Kreisler
  • B Laquente
  • J R Germa
  • M Martinez Villacampa
  • V Moreno
  • E Guino
  • M J Paules
  • G Soler
  • A Lopez-Doriga
  • R Salazar
  • M P Sáinz Pelayo
  • M Rigla
  • I Barroeta-Espar
  • R Delgado-Mederos
  • N Pujol
  • Inmaculada Coll
  • Arturo Oliver
  • Rosa Ortín
  • Ruth Forner
  • R Ortín
  • E Martinez-Sanchez
  • B Menendez
  • I Coll
  • C Vallve
  • J M Pou
  • A de Leiva
  • J Blangero
  • M Borell
  • S Slifer
  • L Almasy
  • W Stone

Detail Information

Publications17

  1. ncbi request reprint Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)
    J Mateo
    Haematology Department, Hospital de Sant Pau, Barcelona, Spain
    Blood Coagul Fibrinolysis 9:71-8. 1998
    ..In conclusion, individuals carrying anticoagulant deficiencies have an increased risk of thrombosis, especially those with antithrombin, protein C or type I protein S deficiencies...
  2. ncbi request reprint Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs
    Jose Mateo
    Thrombosis and Hemostasis Unit, Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Thromb Haemost 95:386-7. 2006
  3. ncbi request reprint Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis
    J M Soria
    Unitat d Hemostàsia i Trombosi Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Blood 95:2780-5. 2000
    ..Blood. 2000;95:2780-2785)..
  4. ncbi request reprint Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies
    I Tirado
    Thrombosis and Hemostasis Unit, Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Haematologica 86:1200-8. 2001
    ....
  5. ncbi request reprint Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Avda Sant Antoni Ma Claret 167, 08025 Barcelona, Spain
    Haematologica 84:627-32. 1999
    ..Here, we describe a pedigree including both heterozygous and homozygous subjects for prothrombin (PT) 20210 A...
  6. ncbi request reprint The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barceolan, Spain
    Thromb Haemost 80:366-9. 1998
    ..The prevalence found in this study for healthy people is the highest reported to date. The 20210 A variant appears to be the most prevalent genetic risk factor among patients with thrombosis in our geographical area...
  7. ncbi request reprint Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients
    A Santamaria
    Thrombosis and Hemostasis Unit, Department of Hematology, Universitat Autonoma de Barcelona, Hospital de Santa Creu i Sant Pau, Barcelona, Spain
    Int J Clin Pract 61:1819-23. 2007
    ..Ischaemic stroke (IS) is a complex disease that involves genetic and environmental factors. The role of factor XI (FXI) in arterial thrombosis is unclear. We have investigated the risk of IS related to FXI levels in a case-control study...
  8. ncbi request reprint Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels
    A Santamaria
    Department of Hematology, Hospital de la Santa Creu i Sant Pau, C Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain
    Stroke 34:2387-91. 2003
    ..The relevance of TAFI in thromboembolic disease is unclear. We have investigated the risk of ischemic stroke (IS) in relation to plasma levels of functional TAFI...
  9. doi request reprint [Limitations of anticoagulant therapy]
    J Marti-Fabregas
    Unidad de Enfermedades Vasculares Cerebrales, Servicio de Hematologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Neurologia 27:27-32. 2012
    ..The introduction of oral anticoagulants that would aid the administration of these agents with equal or greater efficacy and lower risk is required...
  10. ncbi request reprint Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Thromb Haemost 85:88-92. 2001
    ..However, since these phenotypes show a high degree of environmental correlation, it is also likely that the same environmental factors influence them co-jointly...
  11. ncbi request reprint Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time
    J C Souto
    Unitat d Hemostasia i Trombosi, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Arterioscler Thromb Vasc Biol 20:2024-8. 2000
    ..This study is unique because it used a combined linkage and association test, which indicated that the ABO locus itself has a functional effect on these plasma phenotypes...
  12. ncbi request reprint Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene
    A Santamaria
    Thrombosis and Haemostasis Unit, Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
    Haematologica 86:965-71. 2001
    ..However, there are only few studies on the risk of VTE in women with inherited thrombophilia who use oral contraceptives...
  13. doi request reprint [Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?]
    A Vidal-Jordana
    Servicio de Neurologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
    Neurologia 27:136-42. 2012
    ..We analyzed the risks and benefits of antiplatelet therapy (AG) against the resumption of anticoagulation with vitamin K antagonists (AVK) in a series of patients...
  14. ncbi request reprint Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy
    M Constans
    Hemostasis and Thrombosis Unit, Department of Hematology, Hospital de Santa Creu i Sant Pau, Barcelona, Spain
    Int J Clin Pract 61:212-7. 2007
    ..Two patients developed pruritus at the punction site. Fixed-dose high-risk thromboprophilactic therapy with bemiparin (Hibor) is safe and effective as a bridging therapy in patients under OAT who require GC or CC...
  15. doi request reprint Clinicopathological risk factors of Stage II colon cancer: results of a prospective study
    C Santos
    Department of Medical Oncology, Institut Català d Oncologia Institut d Investigació Biomèdica de Bellvitge IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    Colorectal Dis 15:414-22. 2013
    ..The aim of this study was to analyse the prognostic impact of clinicopathological factors that may help guide treatment decisions in Stage II colon cancer...
  16. ncbi request reprint Physical training decreases plasma thrombomodulin in type I and type II diabetic patients
    M Rigla
    Department of Endocrinology and Nutrition, Hospital de Sant Pau, , Spain
    Diabetologia 44:693-9. 2001
    ....
  17. ncbi request reprint Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population
    Amparo Santamaria
    Unit of Haemostasis and Thrombosis, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
    Am J Hematol 76:348-52. 2004
    ..We also found no correlation of functional TAFI levels related to any other hemostatic factors...